About Gianluca
Gianluca joined Alexion in October 2019 and currently leads the company’s integrated Development, Regulatory and Safety organization. Previously, he served in various roles at Sanofi Genzyme, including Head of Development for Rare Diseases and Gene Therapy. He has served on the Board of Directors of Imbria Pharmaceuticals for two years, and is currently Board Member of Timber Pharmaceuticals, as well as scientific advisor for the Smith-Magenis Syndrome Research Foundation.
Gianluca holds an MD degree from University Campus Bio-Medico and a PhD in Immunology from Sapienza University, both in Rome, Italy, and completed a Post Doctoral Research Fellowship in Immunology at the Pasteur Institute in Paris, France.
